Indirect Holdings
-
Cellbxhealth PLC Discloses Stake in Company
A significant shift in voting rights occurred on December 18, 2025, with a new entity crossing a 29.9% threshold, encompassing both direct and indirect holdings. This triggered regulatory scrutiny. The disclosure followed a period of extreme price volatility, with the stock trading at a 95.2% discount to its 52-week high. This substantial stake acquisition amidst a de-rated stock raises questions about distressed asset plays versus strategic consolidation.
